TXN · Texas Instruments Incorporated

Current Thesis

Texas Instruments’ analog and data-center recovery thesis needs both Q3 revenue meeting its July guidance and a weekly close above the broken $272 shelf; a weekly close below $250 would invalidate the recovery case. The measured improvement is in price: the adjusted daily close was $268.7 on 2026-09-11, compared with $258.64 on 2026-08-28. The former shelf remains unreclaimed.

The inference is that the narrative is maturing — Cantor Fitzgerald reiterated Neutral and its $340 analyst target on 2026-09-09 while describing weaker investor sentiment across analog semiconductors. That supports continued attention to an established recovery story; it does not establish expanding participation. Cantor’s sentiment assessment is its own view, reported by Investing.com.

The earlier saturation diagnosis was stronger than the evidence supported. The September price recovery weakens that interpretation, while the available coverage sample cannot establish whether the story is crowded.

Bullish and bearish views on Texas Instruments Incorporated

The model's bull view on Texas Instruments Incorporated (TXN), in brief: Reported growth supports the recovery. Texas Instruments’ 2026-07-22 Q2 release reported revenue of $5.46 billion, up 23% year over year, and earnings per share of $2.14. Industrial, data-center and automotive demand contributed to growth, according to Reuters’ account of the… The bear view: The broken shelf remains overhead. The 2026-09-11 adjusted close of $268.7 remains below the $272 shelf identified in the 2026-08-16 published analysis. The market has therefore not yet supplied the price confirmation required by this thesis. The broader decline remains… Both cases follow in full.

Bull Case

• Reported growth supports the recovery. Texas Instruments’ 2026-07-22 Q2 release reported revenue of $5.46 billion, up 23% year over year, and earnings per share of $2.14. Industrial, data-center and automotive demand contributed to growth, according to Reuters’ account of the release.
• Guidance provides a measurable test. On 2026-07-22, management guided Q3 revenue to $5.65–6.15 billion and earnings per share to $2.23–2.57. Revenue below that floor would contradict the operating recovery case at the next report. Reuters
• Momentum has recovered from August. The 14-day relative strength index (RSI) measured 54.0 on 2026-09-11, versus 31.1 on 2026-08-28 in the adjusted daily-bar record. This measures improved momentum; it does not establish a durable base.

Bear Case

• The broken shelf remains overhead. The 2026-09-11 adjusted close of $268.7 remains below the $272 shelf identified in the 2026-08-16 published analysis. The market has therefore not yet supplied the price confirmation required by this thesis.
• The broader decline remains measurable. As of 2026-09-11, the shares were down 10.3% over three months and 18.7% below the adjusted 52-week high of $330.59. The rebound has not erased that weakness.
• Analyst attention is not demand. Cantor’s 2026-09-09 reiteration retained a Neutral rating despite its $340 target. Neither that target nor its favorable industry commentary measures actual buying interest. Investing.com

Setup & Price Structure

The 2026-09-11 reference close of $268.7 places the market below the former $272 shelf and above the previously published $250 weekly-close invalidation threshold. The $250 threshold is an analytical boundary, not a verified moving average or demonstrated support level. A weekly close above $272 would satisfy the price component of the recovery case; Q3 revenue confirmation remains a separate requirement.

Positioning evidence is incomplete. The available headlines dated 2026-09-10 and 2026-09-11 concern alternative artificial-intelligence investments and historical shareholder returns. That sample is too small to support a retail-crowding claim. No current moving-average value, fund-flow series or verified insider-transaction evidence is available for this assessment.

Catalyst Calendar (next 30 days)

• ~2026-10-20, estimated Q3 results. This event lies beyond the next 30 days but is the operating test on which the thesis turns. Barchart lists 2026-10-20; the date remains unconfirmed by Texas Instruments in the available evidence. The report tests the revenue guidance issued on 2026-07-22. Barchart earnings calendar

Elapsed catalysts

• ~2026-09-17, estimated dividend announcement. This remains an unconfirmed calendar estimate. Texas Instruments announced its previous annual increase on 2025-09-18, raising the quarterly dividend 4% to $1.42 per share, with formal declaration following separately. A new announcement would establish the next cash-return commitment; its timing alone would not validate semiconductor demand. (passed 3d ago)

What Would Change Our Mind

Failure of the September recovery would end the price case: a weekly close below $250 breaches the published analytical boundary. Separately, Q3 revenue below the $5.65 billion floor issued on 2026-07-22 would invalidate the operating premise even if the market remained above that level.

The positive resolution requires Q3 revenue at or above that floor and a weekly close above the former $272 shelf. A dividend announcement alone cannot meet those conditions. Absence of an announcement on the estimated 2026-09-17 date would invalidate the calendar estimate, without demonstrating that capital expenditure caused a cash constraint.

Correlation Notes

This is a single-name recovery assessment; a semiconductor group move cannot substitute for Texas Instruments’ revenue and price tests. Cantor’s 2026-09-09 commentary grouped Texas Instruments with Analog Devices, NXP, Microchip and ON Semiconductor, providing a named industry comparison rather than a measured correlation. Investing.com

The available 2026-09-11 price snapshot contains no matched peer-return series. It cannot establish a correlation coefficient or show whether the recent rebound was company-specific. Data-center demand supports the indirect artificial-intelligence exposure described in the 2026-07-22 earnings coverage, but no separately quantified artificial-intelligence revenue contribution is established here.